Paradoxical elevation of serum cholesterol by clofibrate in patients with primary biliary cirrhosis
Open accessThe claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
PRIMARY BILIARY CIRRHOSIS. CHRONIC NON-SUPPURATIVE DESTRUCTIVE CHOLANGITIS.
Rubin, E., Schaffner, F., & Pópper, H. (1965) · PubMed · Cited by 375 · see citing works
Self-citationAvoy, D. R., Swyryd, E. A., & Gould, R. G. (1965) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39306-8 · Cited by 188 · see citing works
Jones, A. L., & Armstrong, D. T. (1965) · Experimental Biology and Medicine · doi:10.3181/00379727-119-30396 · Cited by 100 · see citing works
Reduction of Cholesterol and Lipids in Man by Ethyl p-Chlorophenoxyisobutyrate
HELLMAN, L., ZUMOFF, B., KESSLER, G., KARA, E., RUBIN, I. L., & ROSENFELD, R. S. (1963) · Annals of Internal Medicine · doi:10.7326/0003-4819-59-4-477 · Cited by 77 · see citing works
Low Excretion of Fecal Bile Acids in a Family with Hypercholesterolemia
Miettinen, T. A., Pelkonen, R., Nikkilä, E. A., & Heinonen, O. P. (1967) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1967.tb10890.x · Cited by 58 · see citing works
ORAL-CONTRACEPTIVE OPPOSITION TO HYPOCHOLESTEROLqMIC ACTION OF CLOFIBRATE
Smith, R. B. (1968) · The Lancet · doi:10.1016/s0140-6736(68)92195-8 · Cited by 13 · see citing works
Effect of Atromid on Requirements of Warfarin
Roberts, S. D., & Pantridge, J. F. (1963) · Journal of Atherosclerosis Research · doi:10.1016/s0368-1319(63)80049-6 · Cited by 12 · see citing works
Synthesis of Serum and Sub-cellular Liver Cholesterol Esters in Fasted and Fed Rats
Swell, L., & Law, M. D. (1968) · Journal of Nutrition · doi:10.1093/jn/95.2.141 · Cited by 10 · see citing works
Effect of clofibrate on serum and hepatic lipids in nephrotic rats.
Jc, H., Connor, W. E., Ml, A., & Ed, W. (1968) · PubMed · Cited by 10 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- Sperber, I. 1965. Biliary secretion of organic anions and its influence on bile flow , p. 457- 467. In W. Taylor [ed.), The biliary system .
Cited by
Sorted by citations
Schwab, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-16483-5_4730 · Cited by 1,241 · see citing works
Lindor, K. D., Gershwin, E. M., Poupon, R., Kaplan, M., Bergasa, N. V., & Heathcote, J. E. (2009) · Hepatology · doi:10.1002/hep.22906 · Cited by 1,099 · see citing works
Lindor, K. D., Bowlus, C. L., Boyer, J., Levy, C., & Mayo, M. (2019) · Hepatology · doi:10.1002/hep.30145 · Cited by 913 · see citing works
Hypercholesterolemia and Atherosclerosis in Primary Biliary Cirrhosis: What Is the Risk?
Crippin, J. S., Lindor, K. D., Jorgensen, R., Kottke, B. A., Harrison, J. M., Murtaugh, P. A., & Dickson, R. E. (1992) · Hepatology · doi:10.1002/hep.1840150518 · Cited by 149 · see citing works
Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy
Purohit, T. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i7.926 · Cited by 118 · see citing works
Primary biliary cirrhosis—presentation and diagnosis
Leuschner, U. (2003) · Clinics in Liver Disease · doi:10.1016/s1089-3261(03)00101-6 · Cited by 106 · see citing works
Approach to a Patient with Elevated Serum Alkaline Phosphatase
Siddique, A., & Kowdley, K. V. (2012) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.03.012 · Cited by 100 · see citing works
5 Dyslipoproteinaemia of liver disease
Miller, J. P. (1990) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80080-1 · Cited by 86 · see citing works
The hypercholesterolaemia of obstructive jaundice.
McIntyre, N., Harry, D. S., & Pearson, A. J. G. (1975) · Gut · doi:10.1136/gut.16.5.379 · Cited by 56 · see citing works
Turnberg, L. A., Mahoney, M. P., Gleeson, M. H., Freeman, C. B., & Gowenlock, A. H. (1972) · Gut · doi:10.1136/gut.13.12.976 · Cited by 51 · see citing works
Levy, C., & Lindor, K. (2003) · Clinical Liver Disease · doi:10.1016/s1089-3261(03)00097-7 · Cited by 41 · see citing works
Cholesterol metabolism in primary biliary cirrhosis during simvastatin and UDCA administration
Puppo, M. D., Kienle, M. G., Crosignani, A., Petroni, M. L., Amati, B., Zuin, M. G., & Podda, M. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31668-0 · Cited by 41 · see citing works
Fibrate treatment for primary biliary cirrhosis
Cuperus, F. J. C., Halilbasic, E., & Trauner, M. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000056 · Cited by 36 · see citing works
Effects of Clofibrate in Primary Biliary Cirrhosis Hypercholesterolemia and Gallstones
Summerfield, J. A., Elias, E., & Sherlock, S. (1975) · Gastroenterology · doi:10.1016/s0016-5085(19)32419-9 · Cited by 29 · see citing works
Moreno‐Otero, R., Lisker‐Melman, M., & Jones, E. A. (1989) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30645-9 · Cited by 22 · see citing works
Xu, Q., Zhu, W., & Yin, Y. (2023) · Medicine · doi:10.1097/md.0000000000036039 · Cited by 20 · see citing works
Witte, E. (1975) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(08)70210-8 · Cited by 14 · see citing works
Treatment options for primary biliary cirrhosis and primary sclerosing cholangitis
Levy, C., & Lindor, K. D. (2003) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-003-0010-0 · Cited by 13 · see citing works
Treatment of Primary Biliary Cirrhosis with Ursodeoxycholic Acid, Budesonide and Fibrates
Poupon, R. Y. (2011) · Digestive Diseases · doi:10.1159/000324139 · Cited by 13 · see citing works
Lazaridis, K. N., & Lindor, K. D. (1999) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-999-0051-0 · Cited by 12 · see citing works
A clinical pharmacologist's view of drug hepatotoxicity
Dujovne, C. A. (1977) · Pharmacological Research Communications · doi:10.1016/s0031-6989(77)80049-0 · Cited by 12 · see citing works
Novel Therapies on Primary Biliary Cirrhosis
Czul, F., & Levy, C. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.08.006 · Cited by 10 · see citing works
Powell, E. E., & Kroon, P. A. (1992) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1992.tb00966.x · Cited by 7 · see citing works
James, S. P. (1985) · New England Journal of Medicine · doi:10.1056/nejm198504183121610 · Cited by 7 · see citing works
Kühn, H. A. (1974) · Ergebnisse der inneren Medizin und Kinderheilkunde · doi:10.1007/978-3-642-65879-2_1 · Cited by 4 · see citing works
Mayo, M. J., & Thiele, D. L. (2015) · Yamada's Textbook of Gastroenterology · doi:10.1002/9781118512074.ch100 · Cited by 2 · see citing works
Truswell, A. S. (1971) · BMJ · doi:10.1136/bmj.2.5755.223-a · Cited by 2 · see citing works
Douglas, J. F. (1970) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)60340-1 · Cited by 1 · see citing works
(2007) · CRC Press eBooks · doi:10.1201/b13464-12 · Cited by 1 · see citing works
Treatment of primary biliary cirrhosis
Poupon, R. Y., & Corpechot, C. (2013) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2014.870031
James, S. P. (2011) · doi:10.1002/9781119950509.ch21
Safe Prescribing in Liver Disease
Singh, A. P. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108776936.021
Poupon, R. Y., Chazouillères, O., & Corpechot, C. (2008) · Hepatology · doi:10.1002/hep.22689
- Authors
- Schaffner, F.
- Affiliations
- City University of New York (US)
- Corresponding author
- Schaffner, Fenton
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 1969-09
- Volume
- 57
- Issue
- 3
- Pages
- 253-255
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2463973101
- Cited by
- 33
- References
- 9
- Citations by year
- 2023: 1 · 2020: 1 · 2018: 1 · 2015: 3 · 2014: 1 · 2013: 1 · 2012: 1
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (AM 03846)
- U.S. Public Health Service
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Keywords
- clofibrate, primary biliary cirrhosis, xanthoma, adverse drug reactions, lipid-lowering therapy
- MeSH terms
- Hypolipidemic Agents, Cholesterol, Female, Humans, Hypercholesterolemia, Lipids, Liver Cirrhosis, Biliary, Male, Middle Aged, Xanthomatosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review